Cite
The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis
MLA
Jie Chen, et al. “The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.” Computational Intelligence and Neuroscience, vol. 2022, July 2022, pp. 1–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....90e558cbe93e44c87ba4a4b6a36b86cf&authtype=sso&custid=ns315887.
APA
Jie Chen, Hua Liu, Wenjun Yin, Zhengguang Xu, Zekai Chen, & Wingkeung Yiu. (2022). The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis. Computational Intelligence and Neuroscience, 2022, 1–11.
Chicago
Jie Chen, Hua Liu, Wenjun Yin, Zhengguang Xu, Zekai Chen, and Wingkeung Yiu. 2022. “The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.” Computational Intelligence and Neuroscience 2022 (July): 1–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....90e558cbe93e44c87ba4a4b6a36b86cf&authtype=sso&custid=ns315887.